Preventive Strategies for Nonalcoholic Fatty Liver Disease After Liver Transplantation

Publication date: Available online 30 May 2019Source: Journal of Clinical and Experimental HepatologyAuthor(s): Narendra S. Choudhary, Sanjiv SaigalPost-transplant nonalcoholic fatty liver disease (NAFLD) or nonalcoholic steatohepatitis (NASH) is common and can be recurrent or de novo. The available data suggest that progression of fibrosis is accelerated in these patients compared to NASH in general population. The long-term data suggest more risk of metabolic syndrome and associated metabolic comorbidities and cardiovascular disease in these patients. The current review focuses on prevalence and prevention/treatment of post-transplant NAFLD or NASH.
Source: Journal of Clinical and Experimental Hepatology - Category: Gastroenterology Source Type: research